Director/PCA Shareholding
CFO Giles Wilson and his wife purchased shares at £0.91 per share on 1 September 2025.
- Giles Wilson purchase price £0.91377 per share
- Giles Wilson shares purchased 105,838
- Katie Wilson purchase price £0.911447 per share
- Katie Wilson shares purchased 30,019
- Giles Wilson total holding 260,193 Ordinary Shares
Select text to share a quote on X · sign in to keep highlights & notes in your DOCS notes
The Company announces that it has been notified of the following transactions in the Company's Ordinary 1p shares (the 'shares') undertaken by a director / person discharging managerial responsibility ('PDMR') and a person closely associated with them ('PCA'):
On 1 September 2025, Giles Wilson, Chief Financial Officer, purchased 105,838 shares in his ISA at a price of £0.91377 per share, having sold 105,785 shares at a price of £0.8965 per share.
On 1 September 2025, Katie Wilson, a PCA of Giles Wilson, purchased 30,019 shares in her ISA at a price of £0.911447 per share, having sold 30,000 shares at a price of £0.910823 per share.
Following these transactions, which entail the movement of holdings into ISAs, Giles's overall beneficial interest in the Company's shares is 260,193 Ordinary Shares.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Giles Wilson | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR (Chief Financial Officer) | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| a) | Name | Dr. Martens plc | ||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 1 September 2025 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Giles Wilson | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR (Chief Financial Officer) | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| a) | Name | Dr. Martens plc | ||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||
| b) | Nature of the transaction | Sale of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 1 September 2025 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Katie Wilson | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Person Closely Associated with Giles Wilson, Chief Financial Officer and PDMR | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| a) | Name | Dr. Martens plc | ||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 1 September 2025 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Katie Wilson | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Person Closely Associated with Giles Wilson, Chief Financial Officer and PDMR | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| a) | Name | Dr. Martens plc | ||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||
| b) | Nature of the transaction | Sale of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 1 September 2025 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.